RV

Recipharm Venture Fund

Europe, Stockholms Lan, Sweden, Stockholm

Description

Recipharm Venture Fund is part of Recipharm AB.

Investor Profile

Recipharm Venture Fund has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 50% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series Unknown rounds (top funding stages).
  • Majority of deals are located in Switzerland, Sweden.
  • Strong thematic focus on Biotechnology, Health Care, Life Science.

Stage Focus

  • Series A (50%)
  • Series Unknown (50%)

Country Focus

  • Switzerland (50%)
  • Sweden (50%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Medical
  • Clinical Trials
  • Pharmaceutical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Recipharm Venture Fund frequently co-invest with?

Fourth Swedish National Pension Fund
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1

Which angels does Recipharm Venture Fund often collaborate with?

IF
Europe, Vaud, Switzerland, Epalinges
Shared Deals: 1
Shared Deals: 1
NM
North America, California, United States, Berkeley
Shared Deals: 1
JS
Europe, Stockholms Lan, Sweden, Stockholm
Shared Deals: 1

What are some of recent deals done by Recipharm Venture Fund?

NewBiologix

Epalinges, Vaud, Switzerland

NewBiologix operates as a technology innovation company.

BiotechnologyHealth CareLife ScienceMedical
Series AMay 11, 2023
Amount Raised: $50,309,797
Cinclus Pharma

Mölndal, Vastra Gotaland, Sweden

Cinclus Pharma is a research based biotech company.

BiotechnologyClinical TrialsHealth CarePharmaceutical
Series UnknownMar 4, 2020
Amount Raised: $26,392,035

Find More Investors Like Recipharm Venture Fund

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Recipharm Venture Fund | Pipeseed